Hitting a nerve to disrupt pancreatic tumor formation

Original story from Cold Spring Harbor Laboratory (NY, USA). 

Researchers have discovered that fibroblasts, called myCAFs, send out signals to attract nerve fibers, creating a favorable environment for cancer to grow within pancreatic lesions.

Pancreatic cancer has a lot of nerve. Notoriously tricky to detect, the disease also often resists traditional therapy. So, researchers are urgently looking for new ways to disrupt tumor formation. Though scientists know that the nervous system can help cancer spread, its role in the disease’s earliest stages remains unclear. “One phenomenon that is known is called perineural invasion,” shared Jérémy Nigri, a postdoc in David Tuveson’s lab at Cold Spring Harbor Laboratory (CSHL; NY, USA). “This means cancer cells will migrate within the nerve and use the nerve as a way to metastasize.”

Now, Nigri and his colleagues at CSHL have discovered that the nervous system plays an active part in pancreatic cancer development, even before tumors form. Using 3D imaging, they found that tumor-promoting fibroblasts called myCAFs send out signals to attract nerve fibers. The myCAFs and nerve cells then work together within pancreatic lesions to create a favorable environment for cancer to grow.

RNA nanoparticles for targeted drug delivery

In a mouse study, RNA micelles shrunk metastasized tumors in lungs.

A technique called whole-mount immunofluorescence enabled Tuveson’s team to take 3D photographs of the lesions and surrounding cells. Where standard 2D images show thin nerve fibers as scattered tiny dots, the 3D images reveal a dense network of nerves snaking through and around the myCAFs and lesions. “When we first saw this picture, I was shocked,” Nigri commented. “I couldn’t even imagine the lesion like this. I’d only ever seen it in 2D.”

Nigri and his colleagues ran a series of experiments on mice and human cells that uncovered a vicious cycle between myCAFs and nerves. They found myCAFs give off signals that attract nerve fibers from the sympathetic nervous system, which is responsible for our fight-or-flight response. These nerve fibers release the neurotransmitter norepinephrine, which binds to the fibroblasts and triggers a calcium spike that further activates myCAFs. This spike not only promotes pre-cancerous growth, but also pulls in even more nerve fibers, locking the system into a dangerous self-reinforcing loop.

“In one experiment, we use a neurotoxin to disable the sympathetic nervous system,” Nigri explained. “We show reduced fibroblast activation and a nearly 50% reduction in tumor growth.”

Because the myCAF-nerve loop happens so early, disrupting this cycle could lead to potential new therapies. The findings suggest that clinically available drugs, including doxazosin, may be effective when combined with standard treatments like chemotherapy or immunotherapy. “The next step will be to study this more in detail and try to find a way to block the crosstalk between fibroblasts and nerves,” Nigri concluded. “With support from groups like the Lustgarten Foundation and Pancreatic Cancer Action Network, we hope to one day help improve patient outcomes.”

This article has been republished from the following materials. Material may have been edited for length and house style. For further information, please contact the cited source. Our press release publishing policy can be accessed here.